title: Response to “Methylenetetrahydrofolate reductase gene polymorphisms contribute to acute myeloid leukemia and chronic myeloid leukemia susceptibilities: appraisal of a recent meta-analysis” by Fang Wang and Prof. Guoping Sun.
authors.forename: Hairong
authors.initials: H
authors.lastname: He
authors.forename: Gonghao
authors.initials: G
authors.lastname: He
authors.forename: Taotao
authors.initials: T
authors.lastname: Wang
authors.forename: Jiangxia
authors.initials: J
authors.lastname: Cai
authors.forename: Yan
authors.initials: Y
authors.lastname: Wang
authors.forename: Xiaowei
authors.initials: X
authors.lastname: Zheng
authors.forename: Yalin
authors.initials: Y
authors.lastname: Dong
authors.forename: Jun
authors.initials: J
authors.lastname: Lu
mesh_terms: D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000235:genetics*; D015470:Leukemia, Myeloid, Acute / Q000235:genetics*; D042965:Methylenetetrahydrofolate Reductase (NADPH2) / Q000235:genetics*
chemical_list: D042965:Methylenetetrahydrofolate Reductase (NADPH2)